Spots Global Cancer Trial Database for keratosis, actinic
Every month we try and update this database with for keratosis, actinic cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Evaluation of Non-inferiority and Tolerability of the Device PHOS-ISTOS | NCT03076892 | Keratosis, Acti... | Aktilite® Galde... PHOS ISTOS PDT | 18 Years - | University Hospital, Lille | |
| Levulan PDT Versus Vehicle for Extremity Actinic Keratoses (AK) | NCT01458587 | Keratosis, Acti... | Aminolevulinic ... Vehicle PDT (VE... | 18 Years - | DUSA Pharmaceuticals, Inc. | |
| IM Versus 5-FU Versus IMI Versus MAL-PDT in Treatment of Actinic Keratosis | NCT02281682 | Keratosis, Acti... | Imiquimod 5-fluorouracil Ingenol mebutat... methylaminolevu... | 18 Years - | Maastricht University Medical Center | |
| The Use of Microneedles to Expedite Treatment Time in Photodynamic Therapy | NCT02594644 | Keratosis, Acti... | Microneedle Rol... Aminolevulinic ... Blue Light | 18 Years - | University of California, Davis | |
| A Multi-Center Study to Evaluate the Efficacy and Safety of KX2-391 Ointment 1% on Actinic Keratosis on Face or Scalp (AK004) | NCT03285490 | Actinic Keratos... | KX2-391 Ointmen... Placebo | 18 Years - | Almirall, S.A. | |
| OCT and Invasion in Cutaneous Skin Lesions | NCT06014697 | Cutaneous Squam... Bowen's Disease Actinic Keratos... Keratosis, Acti... Diagnosis | Optical Coheren... Clinical assess... | - | Maastricht University Medical Center | |
| UV Sensor in Patients With Actinic Keratosis | NCT05481073 | Keratosis, Acti... | UV sensor | 65 Years - | Almirall, S.A. | |
| Maximal Use Systemic Exposure Study of Levulan Kerastick (MUSE 2) | NCT02628236 | Keratosis, Acti... | Aminolevulinic ... BLU-U | 18 Years - | DUSA Pharmaceuticals, Inc. | |
| A Multi-Center Study to Evaluate the Efficacy and Safety of KX2-391 Ointment 1% on Actinic Keratosis on Face or Scalp (AK004) | NCT03285490 | Actinic Keratos... | KX2-391 Ointmen... Placebo | 18 Years - | Almirall, S.A. | |
| Study to Evaluate Safety and Tolerability of BF-200 ALA (Ameluz®) for Photodynamic Therapy in the Treatment of the Expanded Field of Actinic Keratosis on Face and Scalp | NCT05060237 | Actinic Keratos... Keratosis, Acti... Keratosis | BF-200 ALA and ... | 18 Years - | Biofrontera Bioscience GmbH | |
| Microwave Treatment for Actinic Keratosis | NCT05636800 | Keratosis, Acti... | Swift System | 18 Years - 85 Years | Blackwell Device Consulting | |
| Maximal Use Systemic Exposure (MUSE) Study of Levulan Kerastick | NCT02281136 | Keratosis, Acti... | Aminolevulinic ... BLU-U | 18 Years - | DUSA Pharmaceuticals, Inc. | |
| A Study to Evaluate the Efficacy and Safety of Tirbanibulin Ointment in Adult Participants With Actinic Keratosis | NCT06135415 | Keratosis, Acti... | Tirbanibulin Vehicle ointmen... | 18 Years - | Almirall, S.A. | |
| A Study to Evaluate the Safety and Tolerability of Tirbanibulin Ointment 1% in Adult Participants With Actinic Keratosis | NCT05279131 | Keratosis, Acti... | Tirbanibulin oi... | 18 Years - | Almirall, S.A. | |
| A Trial of Polypodium Leucotomos in Preventing Skin Cancer and Its Precursors | NCT02813902 | Keratosis, Acti... Keratosis Skin Neoplasms | Heliocare with ... Sugar Pill | 18 Years - | Massachusetts General Hospital | |
| A Multi-Center Study to Evaluate the Efficacy and Safety of KX2-391 Ointment 1% on AK on Face or Scalp | NCT03285477 | Actinic Keratos... | Placebo KX2-391 Ointmen... | 18 Years - | Almirall, S.A. | |
| Study to Evaluate Safety and Tolerability of BF-200 ALA (Ameluz®) for Photodynamic Therapy in the Treatment of the Expanded Field of Actinic Keratosis on Face and Scalp | NCT05060237 | Actinic Keratos... Keratosis, Acti... Keratosis | BF-200 ALA and ... | 18 Years - | Biofrontera Bioscience GmbH | |
| Evaluation of Non-inferiority and Tolerability of the Device PHOS-ISTOS | NCT03076892 | Keratosis, Acti... | Aktilite® Galde... PHOS ISTOS PDT | 18 Years - | University Hospital, Lille | |
| The Use of Microneedles to Expedite Treatment Time in Photodynamic Therapy | NCT02594644 | Keratosis, Acti... | Microneedle Rol... Aminolevulinic ... Blue Light | 18 Years - | University of California, Davis | |
| Evaluating the Device FLEXITHERALIGHT Compared to the Conventional Photodynamic Therapy | NCT03076918 | Keratosis, Acti... | FLEXITHERALIGHT... Aktilite® Galde... | 18 Years - | University Hospital, Lille | |
| Maximal Use Systemic Exposure (MUSE) Study of Levulan Kerastick | NCT02281136 | Keratosis, Acti... | Aminolevulinic ... BLU-U | 18 Years - | DUSA Pharmaceuticals, Inc. | |
| Photodynamic Therapy of Actinic Keratosis of the Face and Scalp With and Without Prior Curettage | NCT03697590 | Keratosis, Acti... | No curettage Curettage | 18 Years - | Bispebjerg Hospital | |
| Photodynamic Therapy of Actinic Keratosis of the Face and Scalp With and Without Prior Curettage | NCT03697590 | Keratosis, Acti... | No curettage Curettage | 18 Years - | Bispebjerg Hospital | |
| Patient and Clinician Reported Outcomes for Tirbanibulin Effectiveness and Safety in Actinic Keratosis | NCT05260073 | Keratosis, Acti... | Tirbanibulin (K... | 18 Years - | Almirall, S.A. | |
| Maximal Use Systemic Exposure Study of Levulan Kerastick (MUSE 2) | NCT02628236 | Keratosis, Acti... | Aminolevulinic ... BLU-U | 18 Years - | DUSA Pharmaceuticals, Inc. |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
